Determination of trazodone and its metabolite, 1-m-chlorophenyl-piperazine, in human plasma and red blood cell samples by HPLC

Clin Biochem. 1997 Mar;30(2):149-53. doi: 10.1016/s0009-9120(96)00166-x.

Abstract

Objectives: To develop an HPLC method for the analysis of trazodone and its metabolite, 1-m-chlorophenyl-piperazine (m-CPP), in human plasma and red blood cells.

Design and methods: The analytes were extracted by heptane containing 1.5% isoamyl alcohol, back extracted into phosphoric acid and analyzed by reverse phase HPLC with UV detection.

Results: In seven randomly selected, male, human subjects plasma concentrations (nmol/l) were 380-5841 for trazodone and 14-237 for m-CPP while those in packed red blood cells were 98-634 for trazodone and 15-155 for m-CPP. Plasma trazodone concentrations were 4-11-fold higher than those in red blood cells while those of m-CPP were about equal. This may be the first report on concentrations of trazodone and m-CPP in human red blood cells.

Conclusions: This sensitive method can be used for monitoring trazodone and m-CPP in human plasma and red blood cells.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Chromatography, High Pressure Liquid / methods*
  • Erythrocytes / chemistry*
  • Humans
  • Male
  • Middle Aged
  • Piperazines / blood*
  • Serotonin Receptor Agonists / blood*
  • Trazodone / blood*

Substances

  • Piperazines
  • Serotonin Receptor Agonists
  • 1-(3-chlorophenyl)piperazine
  • Trazodone